Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

509 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and tolerability of omalizumab.
Corren J, Casale TB, Lanier B, Buhl R, Holgate S, Jimenez P. Corren J, et al. Among authors: buhl r. Clin Exp Allergy. 2009 Jun;39(6):788-97. doi: 10.1111/j.1365-2222.2009.03214.x. Epub 2009 Mar 17. Clin Exp Allergy. 2009. PMID: 19302249 Review.
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H. Khatri S, et al. Among authors: buhl r. J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23. J Allergy Clin Immunol. 2019. PMID: 30359681 Free article. Clinical Trial.
509 results